RxDoctor Payments Data

John Mitchell, MD

Family Medicine · Coeur D Alene, IDNPI 1770015471

Payments from drug & device makers

$561in general payments, 2019–2025

Across 29 payments — averaging $19.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$150
  • Novo Nordisk$103
  • Exact Sciences$79
  • Teva Pharmaceuticals USA, Inc.$56
  • Pfizer$37
  • Sanofi Pasteur Inc.$33
  • plus $104 from 6 others

What the payments were for

  • Food & beverage$561100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$561 in reported general payments places this provider in the 60th percentile of 803 family medicine providers in Idaho.

See all family medicine providers in Idaho

Medicare billing

Part B allowed, 2024
$61,988
Medicare patients
399
Services billed
829

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban69$82,312
OzempicSemaglutide59$54,560
JardianceEmpagliflozin21$31,543
TrulicityDulaglutide28$31,393
MyrbetriqMirabegron19$18,119
MounjaroTirzepatide17$17,729
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$15,582
XareltoRivaroxaban17$12,437
Stiolto RespimatTiotropium Br/Olodaterol Hcl12$11,726
NeuproRotigotine11$9,626
Tresiba Flextouch U-200Insulin Degludec13$9,335
FarxigaDapagliflozin Propanediol11$6,135
Gabapentin155$3,615
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen82$2,647
Tamsulosin Hcl124$2,201

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$37$82,31269 claims
Novo NordiskOzempic$103$54,56059 claims
Astellas Pharma US IncMyrbetriq$17$18,11919 claims
AstraZenecaFarxiga$150$6,13511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 803 family medicine providers in Idaho.

Other family medicine in Coeur D Alene

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →